10 results on '"Raiteri, Maurizio"'
Search Results
2. Differential blockade by (−)mianserin of the alpha2-adrenoceptors mediating inhibition of noradrenaline and serotonin release from rat brain synaptosomes
- Author
-
Raiteri, Maurizio, Maura, Guido, Gemignani, Anita, and Pittaluga, Anna
- Published
- 1983
- Full Text
- View/download PDF
3. Extracellular protons differentially potentiate the responses of native AMPA receptor subtypes regulating neurotransmitter release.
- Author
-
Pittaluga, Anna, Segantini, Daniela, Feligioni, Marco, and Raiteri, Maurizio
- Subjects
NEUROTRANSMITTERS ,PROTONS ,CATECHOLAMINES ,SYNAPSES ,DOPAMINE ,NEURAL transmission - Abstract
The effects of pH changes on the basal and evoked release of[
3 H]noradrenaline ([3 H]NA) and[3 H]5-hydrohytryptamine ([3 H]5-HT) from hippocampal synaptosomes and of[3 H]dopamine ([3 H]DA) and[3 H]acetylcholine ([3 H]ACh) from striatal and cortical synaptosomes were investigated in rat brain.Changing pH between 6.4 and 8.0 did not affect the spontaneous release of the four[3 H]neurotransmitters; alkalinization to pH 8.8 significantly enhanced release. Acidification to pH 6.4 augmented the AMPA-evoked overflows of[3 H]NA,[3 H]5-HT and[3 H]DA, but not that of[3 H]ACh. In contrast, lowering pH to 6.4 decreased the K+ -evoked overflows of[3 H]NA,[3 H]5-HT,[3 H]DA and[3 H]ACh.AMPA released transmitters in a Ca2+ -dependent, exocytotic manner since its effects, at pH 7.4 or 6.4, were abolished by omitting external Ca2+ or by depleting vesicular transmitter stores with bafilomycin A1. AMPA did not evoke carrier-mediated release because the uptake blockers nisoxetine, 6-nitroquipazine, GBR12909 and hemicholinium-3 could not inhibit the AMPA-induced release of[3 H]NA,[3 H]5-HT,[3 H]DA and[3 H]ACh.Extraterminal acidification to pH 6.4 prevented the potentiating effect of cyclothiazide on the AMPA-evoked release of[3 H]NA,[3 H]DA and[3 H]5-HT, whereas the proton-insensitive AMPA-evoked release of[3 H]ACh, previously found to be cyclothiazide-insensitive at pH 7.4 was cyclothiazide-resistant also at pH 6.4.To conclude, the cyclothiazide-sensitive AMPA receptors mediating release of NA, 5-HT and DA, but not the cyclothiazide-insensitive AMPA receptors mediating the release of ACh, become more responsive when external pH is lowered to pathophysiologically relevant values. The results with cyclothiazide suggest that H+ ions may prevent desensitization of some AMPA receptor subtypes.British Journal of Pharmacology (2005) 144, 293-299. doi:10.1038/sj.bjp.0705960 Published online 27 September 2004 [ABSTRACT FROM AUTHOR]- Published
- 2005
- Full Text
- View/download PDF
4. Noradrenaline uptake inhibitors do not reduce the presynaptic action of clonidine on H-noradrenaline release in superfused synaptosomes.
- Author
-
Maura, Guido, Pittaluga, Anna, Ricchetti, Annamaria, and Raiteri, Maurizio
- Abstract
The interaction between clonidine, as an agonist at the α-autoreceptors regulating noradrenaline release, and inhibitors of noradrenaline neuronal uptake was investigated in superfused synaptosomes, i.e. in conditions preventing accumulation of the released transmitter in the vicinity of presynaptic autoreceptors. Desipramine or cocaine did not decrease the inhibitory action of clonidine on the release of H-noradrenaline evoked by 15 mM KCl from rat cortex synaptosomes, even when the concentration ratio between uptake inhibitor and clonidine was very high. The present results do not support either the hypothesis of an interaction between imidazolines and noradrenaline uptake inhibitors at the level of α-autoreceptors, or that of a functional coupling between presynaptic α-autoreceptors and noradrenaline uptake mechanism. [ABSTRACT FROM AUTHOR]
- Published
- 1984
- Full Text
- View/download PDF
5. Antidepressant treatments and function of glutamate ionotropic receptors mediating amine release in hippocampus
- Author
-
Pittaluga, Anna, Raiteri, Luca, Longordo, Fabio, Luccini, Elisa, Barbiero, Valentina Sara, Racagni, Giorgio, Popoli, Maurizio, and Raiteri, Maurizio
- Subjects
- *
NEUROPHARMACOLOGY , *NEUROSCIENCES , *MEDICAL sciences , *PHARMACOLOGY - Abstract
Abstract: Previous evidences showed that, besides noradrenaline (NA) and 5-hydroxytryptamine (5-HT), glutamate transmission is involved in the mechanism of action of antidepressants (ADs), although the relations between aminergic and glutamatergic systems are poorly understood. The aims of this investigation were to evaluate changes in the function of glutamate AMPA and NMDA receptors produced by acute and chronic administration of the two ADs reboxetine and fluoxetine, selective inhibitors of NA and 5-HT uptake, respectively. Rats were treated acutely (intraperitoneal injection) or chronically (osmotic minipump infusion) with reboxetine or fluoxetine. Isolated hippocampal nerve endings (synaptosomes) prepared following acute/chronic treatments were labelled with [3H]NA or [3H]5-HT and [3H]amine release was monitored during exposure in superfusion to NMDA/glycine, AMPA or K+-depolarization. Acute and chronic reboxetine reduced the release of [3H]NA evoked by NMDA/glycine or by AMPA. The NMDA/glycine-evoked release of [3H]NA was also down-regulated by chronic fluoxetine. Only acute, but not chronic, fluoxetine inhibited the AMPA-evoked release of [3H]5-HT. The release of [3H]NA and [3H]5-HT elicited by K+-depolarization was almost abolished by acute reboxetine or fluoxetine, respectively, but recovered during chronic ADs administration. ADs reduced NMDA receptor-mediated releasing effects in noradrenergic terminals after acute and chronic administration, although by different mechanisms. Chronic treatments markedly reduced the expression level of NR1 subunit in synaptic membranes. The noradrenergic and serotonergic release systems seem to be partly functionally interconnected and interact with glutamatergic transmission to down-regulate its function. The results obtained support the view that glutamate plays a major role in AD activity. [Copyright &y& Elsevier]
- Published
- 2007
- Full Text
- View/download PDF
6. Trafficking of presynaptic AMPA receptors mediating neurotransmitter release: Neuronal selectivity and relationships with sensitivity to cyclothiazide
- Author
-
Pittaluga, Anna, Feligioni, Marco, Longordo, Fabio, Luccini, Elisa, and Raiteri, Maurizio
- Subjects
- *
NEUROTRANSMITTERS , *CENTRAL nervous system , *SYNAPTOSOMES , *SYNAPSES , *NEURONS - Abstract
Abstract: Postsynaptic glutamate AMPA receptors (AMPARs) can recycle between plasma membrane and intracellular pools. In contrast, trafficking of presynaptic AMPARs has not been investigated. AMPAR surface expression involves interactions between the GluR2 carboxy tail and various proteins including glutamate receptor-interacting protein (GRIP), AMPA receptor-binding protein (ABP), protein interacting with C kinase 1 (PICK1), N-ethyl-maleimide-sensitive fusion protein (NSF). Here, peptides known to selectively block the above interactions were entrapped into synaptosomes to study the effects on the AMPA-evoked release of [3H]noradrenaline ([3H]NA) and [3H]acetylcholine ([3H]ACh) from rat hippocampal and cortical synaptosomes, respectively. Internalization of pep2-SVKI to prevent GluR2–GRIP/ABP/PICK1 interactions potentiated the AMPA-evoked release of [3H]NA but left unmodified that of [3H]ACh. Similar potentiation was caused by pep2-AVKI, the blocker of GluR2–PICK1 interaction. Conversely, a decrease in the AMPA-evoked release of [3H]NA, but not of [3H]ACh, was caused by pep2m, a selective blocker of the GluR2–NSF interaction. In the presence of pep2-SVKI the presynaptic AMPARs on noradrenergic terminals lost sensitivity to cyclothiazide. AMPARs releasing [3H]ACh, but not those releasing [3H]NA, were sensitive to spermine, suggesting that they are GluR2-lacking AMPARs. To conclude: (i) release-regulating presynaptic AMPARs constitutively cycle in isolated nerve terminals; (ii) the process exhibits neuronal selectivity; (iii) AMPAR trafficking and desensitization may be interrelated. [Copyright &y& Elsevier]
- Published
- 2006
- Full Text
- View/download PDF
7. Nicotine has a permissive role on the activation of metabotropic glutamate 5 receptors coexisting with nicotinic receptors on rat hippocampal noradrenergic nerve terminals
- Author
-
Parodi, Monica, Patti, Laura, Grilli, Massimo, Raiteri, Maurizio, and Marchi, Mario
- Subjects
- *
CATECHOLAMINES , *TOBACCO , *CALCIUM , *NEUROTRANSMITTERS - Abstract
Abstract: The existence of metabotropic glutamate receptors (mGluRs) on hippocampal noradrenergic nerve terminals and their interaction with coexisting nicotinic acetylcholine receptors (nAChRs) were investigated in superfused rat synaptosomes using [3H]-noradrenaline ([3H]-NA) release as a readout. The selective agonist of group I mGluRs, (S)-3,5-dihydroxyphenylglycine (DHPG), inactive on its own, acquired ability to release [3H]-NA when added together with (−)-nicotine. The effect of DHPG was prevented by 2-methyl-6-(phenylethynyl)-pyridine (MPEP), a selective antagonist of mGluR5, but not by 7-(hydroxyimino)cyclopropane[b]chromen-1-carboxylate ethyl ester (CPCCOEt), selective antagonist of mGluR1. The [3H]-NA release evoked by (−)-nicotine plus DHPG was totally abrogated by the nAChR antagonist mecamylamine. Veratrine mimicked the permissive role of (−)-nicotine on the activation of mGluR5 mediating [3H]-NA release. The mGluR5-mediated component of the [3H]-NA release provoked by DHPG plus (−)-nicotine was blocked by xestospongin C, a selective antagonist of inositoltrisphosphate (IP3) receptors. It can be concluded that (i) release-enhancing mGluRs of subtype 5 exist on hippocampal noradrenergic axon terminals; (ii) activation of mGluR5 to mediate IP3-dependent NA release requires activation of depolarizing nAChRs coexisting on the same terminals. [Copyright &y& Elsevier]
- Published
- 2006
- Full Text
- View/download PDF
8. External pH changes affect NMDA-evoked and spontaneous release of cholecystokinin, somatostatin and noradrenaline from rat cerebrocortical nerve endings
- Author
-
Gemignani, Anita, Paudice, Paolo, Longordo, Fabio, and Raiteri, Maurizio
- Subjects
- *
SOMATOSTATIN , *GASTROINTESTINAL hormones , *CHOLECYSTOKININ , *NORADRENALINE - Abstract
It was previously reported that the K+-evoked release of somatostatin-like immunoreactivity (SRIF-LI) and of cholecystokinin-like immunoreactivity (CCK-LI) from superfused rat cerebrocortical synaptosomes can be enhanced by NMDA or d-serine alone. We here studied the effects of extraterminal pH changes on SRIF-LI and CCK-LI release. Lowering pH from 7.4 to 6.9 or 6.4 abolished the effects of NMDA or d-serine on the K+-evoked peptide release. Identical results were obtained when external pH was raised to 8 or 8.7. Sudden alkalinization of the superfusion medium, in absence of K+-depolarization, induced SRIF-LI or CCK-LI release which was insensitive to NMDA. Based on experiments in Ca2+-free medium and with voltage-sensitive Ca2+ channel (VSCC) blockers, the pH 8.7-induced release of SRIF-LI and CCK-LI was only in part (30–50%) dependent on external Ca2+ and Ca2+ channel activation. In contrast, the alkalinization-evoked release of [
3H ]noradrenaline was highly sensitive to external Ca2+ removal and to blockade of Ca2+ channels with ω-conotoxins. The pH 8.7-evoked SRIF-LI and CCK-LI was about halved in synaptosomes intoxicated with botulinum toxin C1. The results suggest that the pH-sensitive NMDA receptors mediating somatostatin and cholecystokinin release contain NR1 subunits lacking the exon-5 cassette. Alkalinization represents a novel releasing stimulus which elicits neuropeptide release in part by conventional exocytosis and largely by an external Ca2+-independent mechanism. Differently, the release of noradrenaline provoked by alkalinization occurs entirely by conventional exocytosis. [Copyright &y& Elsevier]- Published
- 2004
- Full Text
- View/download PDF
9. Nicotine exerts a permissive role on NMDA receptor function in hippocampal noradrenergic terminals
- Author
-
Risso, Francesca, Grilli, Massimo, Parodi, Monica, Bado, Marcella, Raiteri, Maurizio, and Marchi, Mario
- Subjects
- *
CHOLINERGIC receptors , *NICOTINE , *PROTEIN kinases , *ANTIHYPERTENSIVE agents - Abstract
The coexistence of nicotinic cholinergic receptors (nAChRs) and of N-methyl-d-aspartate (NMDA) receptors on the same noradrenergic axon terminals and the nAChR/NMDA receptor cross-talk were investigated by monitoring the release of noradrenaline (NA) evoked in superfused rat hippocampal synaptosomes by (-)-nicotine and NMDA alone or in combination. In medium containing a physiological concentration (1.2 mM) of Mg2+, the release of [3H]NA was very slightly increased by NMDA plus glycine, whereas it was significantly enhanced by (-)-nicotine. The (-)-nicotine/NMDA combination elicited supraadditive release which was totally abolished by the nAChR blocker mecamylamine and partly prevented by selectively blocking NMDA receptors. Supraadditive [3H]NA release was also observed by exposing synaptosomes to veratrine, but not to ionomycin. The supraadditive release elicited by the (-)-nicotine/NMDA or the veratrine/NMDA combination was sensitive to the protein kinase A/C inhibitor staurosporine and the selective protein kinase A inhibitor H89, but insensitive to the protein kinase C inhibitor Ro 31-8220. It is concluded that (i) release-modulating nAChRs and NMDA receptors coexist on hippocampal noradrenergic axon terminals; and (ii) nicotine permits NMDA receptor activation in the presence of Mg2+, possibly because the nicotine-induced influx of Na+ depolarizes the nerve ending membrane sufficiently to remove the Mg2+ block. [Copyright &y& Elsevier]
- Published
- 2004
- Full Text
- View/download PDF
10. Chronic nicotine causes functional upregulation of ionotropic glutamate receptors mediating hippocampal noradrenaline and striatal dopamine release
- Author
-
Risso, Francesca, Parodi, Monica, Grilli, Massimo, Molfino, Francesca, Raiteri, Maurizio, and Marchi, Mario
- Subjects
- *
NICOTINE , *ACETYLCHOLINE , *NORADRENALINE , *DOPAMINE - Abstract
It has been proposed that (−)-nicotine can activate release-stimulating presynaptic nicotinic acetylcholine receptors (nAChRs) on glutamatergic nerve terminals to release glutamate, which in turn stimulates the release of noradrenaline (NA) and dopamine (DA) via presynaptic ionotropic glutamate receptors on catecholaminergic terminals. The objective of this study was to compare the function of N-methyl-d-aspartate (NMDA) and α-amino-3-hydroxy-5-methylisoxazide-4-propionic acid (AMPA) glutamate receptors in synaptosomes of rat hippocampus and striatum following acute and chronic (−)-nicotine administration. In hippocampal synaptosomes, prelabeled with [
3H ]NA, both the NMDA- and AMPA-evoked releases were higher in (−)-nicotine-treated (10 days) than in (−)-nicotine-treated (1 day) or vehicle-treated (1 or 10 days) rats. In striatal synaptosomes prelabeled with [3H ]DA, the NMDA-evoked, but not the AMPA-evoked, release of [3H ]DA was higher in (−)-nicotine-treated (10 days) than in nicotine-treated (1 day) or vehicle-treated (1 or 10 days) animals. Chronic (−)-nicotine did not affect catecholamine uptake, basal release and release evoked by high-K+ depolarization. Thus, chronic exposure to nicotine enhances the function of ionotropic glutamate receptors mediating noradrenaline release in the hippocampus and dopamine release in the striatum. [Copyright &y& Elsevier]- Published
- 2004
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.